Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lineage Cell Therapeutics (LCTX) Change in Inventory: 2010-2015

Historic Change in Inventory for Lineage Cell Therapeutics (LCTX) over the last 5 years, with Dec 2015 value amounting to $81,000.

  • Lineage Cell Therapeutics' Change in Inventory rose 575.00% to $81,000 in Q4 2015 from the same period last year, while for Dec 2015 it was $75,000, marking a year-over-year decrease of 13.79%. This contributed to the annual value of $75,000 for FY2015, which is 13.79% down from last year.
  • According to the latest figures from Q4 2015, Lineage Cell Therapeutics' Change in Inventory is $81,000, which was up 325.00% from -$36,000 recorded in Q3 2015.
  • Lineage Cell Therapeutics' Change in Inventory's 5-year high stood at $117,184 during Q4 2013, with a 5-year trough of -$36,000 in Q3 2015.
  • Over the past 3 years, Lineage Cell Therapeutics' median Change in Inventory value was $12,205 (recorded in 2013), while the average stood at $23,750.
  • Its Change in Inventory has fluctuated over the past 5 years, first skyrocketed by 8,064.47% in 2013, then tumbled by 800.00% in 2015.
  • Over the past 5 years, Lineage Cell Therapeutics' Change in Inventory (Quarterly) stood at -$9,940 in 2011, then skyrocketed by 83.37% to -$1,653 in 2012, then skyrocketed by 7,189.17% to $117,184 in 2013, then plummeted by 89.76% to $12,000 in 2014, then spiked by 575.00% to $81,000 in 2015.
  • Its Change in Inventory was $81,000 in Q4 2015, compared to -$36,000 in Q3 2015 and -$3,000 in Q2 2015.